Asia Pacific Radiopharmaceuticals Market Report

Asia Pacific Radiopharmaceuticals Market Analysis By Product (Diagnostics: SPECT, PET; Therapeutics: Alpha Emitters, Beta Emitters, Brachytherapy), By Type (Catheter, Doppler OCT, Handheld, Tabletop), By Application (Diagnostics: Cardiology, Neurology, Oncology, Thyroid, Lymphoma; Therapeutics: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumor) And Segment Forecasts to 2024

  • Published Date: Oct 2016
  • Report ID: GVR-1-68038-172-6
  • Number of Pages: 90
  • Format: Electronic (PDF)
  • Historical Data: 2013-2015

Table of Content

Chapter 1 Research Methodology
                    1.1 Information procurement
                    1.2 Data Analysis
Chapter 2 Executive Summary
Chapter 3 Market Snapshot
Chapter 4 Market Variables, Trends & Scope
                    4.1 Market segmentation & scope
                       4.1.1 Market Driver Analysis
                             4.1.1.1 Rising incidence of cancer and cardiovascular disease
                             4.1.1.2 Widening applications of radiopharmaceuticals
                             4.1.1.3 Growing demand for the accurate diagnostic methods
                       4.1.2 Market Restraint Analysis
                             4.1.2.1 Stringent regulation for production, storage, and usage
                             4.1.2.2 High costs involved in the procedure
                    4.2 Radiopharmecuticals - PESTLE Analysis
                    4.3 Industry Analysis - Porter’s
                    4.4 Penetration Index
                    4.5 Radiopharmaceuticals: Buyer profile
                    4.6 List of suppliers
                    4.7 Average Selling Price
Chapter 5 Market Categorization 1: Product Estimates & Trend Analysis
                    5.1 Radiopharmaceuticals market: Product movement analysis
                    5.2 Diagnostic products
                       5.2.1 Diagnostic products market, 2013 - 2024 (USD Million)
                       5.2.2 SPECT
                             5.2.2.1 SPECT products market, 2013 - 2024 (USD Million)
                       5.2.3 TC-99m
                             5.2.3.1 TC-99m market, 2013 - 2024 (USD Million)
                             5.2.3.2 TL-201
                             5.2.3.3 TL-201 market, 2013 - 2024 (USD Million)
                             5.2.3.4 GA-67
                             5.2.3.5 GA-67 market, 2013 - 2024 (USD Million)
                             5.2.3.6 I-123
                                      5.2.3.6.1 I-123 market, 2013 - 2024 (USD Million)
                             5.2.3.7 Other SPECT products
                             5.2.3.8 Other SPECT products market, 2013 - 2024 (USD Million)
                       5.2.4 PET
                             5.2.4.1 PET products market, 2013 - 2024 (USD Million)
                             5.2.4.2 F-18
                                      5.2.4.2.1 F-18 market, 2013 - 2024 (USD Million)
                             5.2.4.3 RB-82
                             5.2.4.4 RB-82 market, 2013 - 2024 (USD Million)
                             5.2.4.5 Other PET products
                                      5.2.4.5.1 Other PET products market, 2013 - 2024 (USD Million)
                    5.3 Therapeutic products
                       5.3.1 Therapeutic products market, 2013 - 2024 (USD Million)
                       5.3.2 Alpha emitters
                             5.3.2.1 Alpha emitters market, 2013 - 2024 (USD Million)
                             5.3.2.2 RA-223
                                      5.3.2.2.1 RA-223 market, 2013 - 2024 (USD Million)
                             5.3.2.3 Other alpha emitters
                                      5.3.2.3.1 Other alpha emitters market, 2013 - 2024 (USD Million)
                       5.3.3 Beta emitters
                             5.3.3.1 Beta emitters market, 2013 - 2024 (USD Million)
                             5.3.3.2 I-131
                                      5.3.3.2.1 I-131 market, 2013 - 2024 (USD Million)
                             5.3.3.3 Y-90
                                      5.3.3.3.1 Y-90 market, 2013 - 2024 (USD Million)
                             5.3.3.4 SM-153
                                      5.3.3.4.1 SM-153 market, 2013 - 2024 (USD Million)
                             5.3.3.5 Re-186
                                      5.3.3.5.1 Re-186 market, 2013 - 2024 (USD Million)
                             5.3.3.6 Lu-117
                                      5.3.3.6.1 Lu-117 market, 2013 - 2024 (USD Million)
                             5.3.3.7 Other beta emitters
                                      5.3.3.7.1 Other beta emitters market, 2013 - 2024 (USD Million)
                       5.3.4 Brachytherapy
                             5.3.4.1 Brachytherapy market, 2013 - 2024 (USD Million)
                             5.3.4.2 Cesium-131
                                      5.3.4.2.1 Cesium-131 market, 2013 - 2024 (USD Million)
                             5.3.4.3 Iodine-125
                                      5.3.4.3.1 Iodine-125 market, 2013 - 2024 (USD Million)
                             5.3.4.4 Palladium-103
                                      5.3.4.4.1 Palladium-103 market, 2013 - 2024 (USD Million)
                             5.3.4.5 Iridium-192
                             5.3.4.6 Iridium-192 market, 2013 - 2024 (USD Million)
                             5.3.4.7 Other brachytherapy products
                                      5.3.4.7.1 Other brachytherapy products market, 2013 - 2024 (USD Million)
Chapter 6 Market Categorization 2: Application Estimates & Trend Analysis
                    6.1 Radiopharmaceuticals market: Application movement analysis
                    6.2 Diagnostic application
                       6.2.1 Diagnostic application market, 2013 - 2024 (USD Million)
                       6.2.2 Cardiology
                             6.2.2.1 Cardiology applications market, 2013 - 2024 (USD Million)
                       6.2.3 Neurology
                             6.2.3.1 Neurology applications market, 2013 - 2024 (USD Million)
                       6.2.4 Oncology
                             6.2.4.1 Oncology applications market, 2013 - 2024 (USD Million)
                       6.2.5 Thyroid
                             6.2.5.1 Thyroid applications market, 2013 - 2024 (USD Million)
                       6.2.6 Lymphoma
                             6.2.6.1 Lymphoma applications market, 2013 - 2024 (USD Million)
                       6.2.7 Other diagnostic application
                             6.2.7.1 Other diagnostic applications market, 2013 - 2024 (USD Million)
                    6.3 Therapeutic application
                       6.3.1. Therapeutic application market, 2013 - 2024 (USD Million)
                       6.3.2 Thyroid
                             6.3.2.1 Thyroid applications market, 2013 - 2024 (USD Million)
                       6.3.3 Bone metastasis
                       6.3.4 Bone metastasis applications market, 2013 - 2024 (USD Million)
                       6.3.5 Lymphoma
                             6.3.5.1 Lymphoma applications market, 2013 - 2024 (USD Million)
                       6.3.6 Endocrine tumor
                             6.3.6.1 Endocrine tumor market, 2013 - 2024 (USD Million)
                       6.3.7 Other therapeutic application
                             6.3.7.1 Other therapeutic applications market, 2013 - 2024 (USD Million)
Chapter 7 Market Categorization 3: Regional Estimates & Trend Analysis, by Product and Applications
                    7.1 Asia Pacific Radiopharmaceuticals market share by region, 2015 & 2024
                    7.2 Southeast Asia
                       7.2.1 Southeast Asia radiopharmaceuticals market, 2013 - 2024 (USD Million)
                       7.2.2 Indonesia
                             7.2.2.1 Indonesia radiopharmaceuticals market, 2013 - 2024 (USD Million)
                       7.2.3 Thailand
                             7.2.3.1 Thailand radiopharmaceuticals market, 2013 - 2024 (USD Million)
                       7.2.4 Laos
                             7.2.4.1 Laos radiopharmaceuticals market, 2013 - 2024 (USD Million)
                       7.2.5 Myanmar
                             7.2.5.1 Myanmar radiopharmaceuticals market, 2013 - 2024 (USD Million)
                       7.2.6 Philippines
                             7.2.6.1 Philippines radiopharmaceuticals market, 2013 - 2024 (USD Million)
                       7.2.7 Malaysia
                             7.2.7.1 Malaysia radiopharmaceuticals market, 2013 - 2024 (USD Million)
                       7.2.8 Vietnam
                             7.2.8.1 Vietnam radiopharmaceuticals market, 2013 - 2024 (USD Million)
                       7.2.9 Cambodia
                             7.2.9.1 Cambodia radiopharmaceuticals market, 2013 - 2024 (USD Million)
                    7.3 Rest of Asia Pacific
                       7.3.1 Rest of Asia Pacific radiopharmaceuticals market, 2013 - 2024 (USD Million)
                       7.3.2 Japan
                             7.3.2.1 Japan radiopharmaceuticals market, 2013 - 2024 (USD Million)
                       7.3.3 China
                             7.3.3.1 China radiopharmaceuticals market, 2013 - 2024 (USD Million)
                       7.3.4 India
                             7.3.4.1 India radiopharmaceuticals market, 2013 - 2024 (USD Million)
Chapter 8 Competitive Landscape
                    8.1 Bayer AG
                       8.1.1 Company Overview
                       8.1.2 Financial Performance
                       8.1.3 Product Benchmarking
                       8.1.4 Strategic Initiatives
                    8.2 Mallinckrodt public limited company
                       8.2.1 Company Overview
                       8.2.2 Financial Performance
                       8.2.3 Product Benchmarking
                       8.2.4 Strategic Initiatives
                    8.3 GE Healthcare
                       8.3.1 Company Overview
                       8.3.2 Financial Performance
                       8.3.3 Product Benchmarking
                       8.3.4 Strategic Initiatives
                    8.4 Jubilant Life Sciences
                       8.4.1 Company Overview
                       8.4.2 Financial Performance
                       8.4.3 Product Benchmarking
                       8.4.4 Strategic Initiatives
                    8.5 Bracco Imaging S.p.A
                       8.5.1 Company Overview
                       8.5.2 Financial Performance
                       8.5.3 Product Benchmarking
                       8.5.4 Strategic Initiatives
                    8.6 Nordion, Inc.
                       8.6.1 Company Overview
                       8.6.2 Financial Performance
                       8.6.3 Product Benchmarking
                       8.6.4 Strategic Initiatives
                    8.7 The Institute for Radioelements (The IRE)
                       8.7.1 Company Overview
                       8.7.2 Financial Performance
                       8.7.3 Product Benchmarking
                       8.7.4 Strategic Initiatives
                    8.8 Australian Nuclear Science & Technology Organization (ANSTO)
                       8.8.1 Company Overview
                       8.8.2 Financial Performance
                       8.8.3 Product Benchmarking
                    8.9 NTP Radioisotopes SOC Ltd.
                       8.9.1 Company Overview
                       8.9.2 Financial Performance
                       8.9.3 Product Benchmarking
                       8.9.4 Strategic Initiatives
                    8.10 Eczacibasi-Monrol
                       8.10.1 Company Overview
                       8.10.2 Financial Performance
                       8.10.3 Product Benchmarking
                       8.10.4 Strategic Initiatives


List of Tables

TABLE 1 Average selling prices for radioisotopes
TABLE 2 Southeast Asia radiopharmaceuticals market, by product, 2013 - 2024 (USD Million)
TABLE 3 Southeast Asia diagnostic radiopharmaceuticals market, by product, 2013 - 2024 (USD Million)
TABLE 4 Southeast Asia SPECT market, by product,2013 - 2024 (USD Million)
TABLE 5 Southeast Asia PET market, by product, 2013 - 2024 (USD Million)
TABLE 6 Southeast Asia therapeutic radiopharmaceuticals market, by product, 2013 - 2024 (USD Million)
TABLE 7 Southeast Asia alpha emitters market, by product, 2013 - 2024 (USD Million)
TABLE 8 Southeast Asia beta emitters market, by product, 2013 - 2024 (USD Million)
TABLE 9 Southeast Asia brachytherapy market, by product, 2013 - 2024 (USD Million)
TABLE 10 Southeast Asia radiopharmaceuticals market, by application, 2013 - 2024 (USD Million)
TABLE 11 Southeast Asia diagnostic application market, by type, 2013 - 2024 (USD Million)
TABLE 12 Southeast Asia therapeutic application market, by type, 2013 - 2024 (USD Million)
TABLE 13 Indonesia radiopharmaceuticals market, by product, 2013 - 2024 (USD Million)
TABLE 14 Indonesia diagnostic radiopharmaceuticals market, by product, 2013 - 2024 (USD Million)
TABLE 15 Indonesia SPECT market, by product, 2013 - 2024 (USD Million)
TABLE 16 Indonesia PET market, by product, 2013 - 2024 (USD Million)
TABLE 17 Indonesia therapeutic radiopharmaceuticals market, by product, 2013 - 2024 (USD Million)
TABLE 18 Indonesia alpha emitters market, by product, 2013 - 2024 (USD Million)
TABLE 19 Indonesia beta emitters market, by product, 2013 - 2024 (USD Million)
TABLE 20 Indonesia brachytherapy market, by product, 2013 - 2024 (USD Million)
TABLE 21 Indonesia radiopharmaceuticals market, by application, 2013 - 2024 (USD Million)
TABLE 22 Indonesia diagnostic application market, by type, 2013 - 2024 (USD Million)
TABLE 23 Indonesia therapeutic application market, by type, 2013 - 2024 (USD Million)
TABLE 24 Thailand radiopharmaceuticals market, by product, 2013 - 2024 (USD Million)
TABLE 25 Thailand diagnostic radiopharmaceuticals market, by product, 2013 - 2024 (USD Million)
TABLE 26 Thailand SPECT market, by product, 2013 - 2024 (USD Million)
TABLE 27 Thailand PET market, by product, 2013 - 2024 (USD Million)
TABLE 28 Thailand therapeutic radiopharmaceuticals market, by product, 2013 - 2024 (USD Million)
TABLE 29 Thailand alpha emitters market, by product, 2013 - 2024 (USD Million)
TABLE 30 Thailand beta emitters market, by product, 2013 - 2024 (USD Million)
TABLE 31 Thailand brachytherapy market, by product, 2013 - 2024 (USD Million)
TABLE 32 Thailand radiopharmaceuticals market, by application, 2013 - 2024 (USD Million)
TABLE 33 Thailand diagnostic application market, by type, 2013 - 2024 (USD Million)
TABLE 34 Thailand therapeutic application market, by type, 2013 - 2024 (USD Million)
TABLE 35 Laos radiopharmaceuticals market, by product, 2013 - 2024 (USD Million)
TABLE 36 Laos diagnostic radiopharmaceuticals market, by product, 2013 - 2024 (USD Million)
TABLE 37 Laos SPECT market, by product, 2013 - 2024 (USD Million)
TABLE 38 Laos PET market, by product, 2013 - 2024 (USD Million)
TABLE 39 Laos therapeutic radiopharmaceuticals market, by product, 2013 - 2024 (USD Million)
TABLE 40 Laos alpha emitters market, by product, 2013 - 2024 (USD Million)
TABLE 41 Laos beta emitters market, by product, 2013 - 2024 (USD Million)
TABLE 42 Laos brachytherapy market, by product, 2013 - 2024 (USD Million)
TABLE 43 Laos radiopharmaceuticals market, by application, 2013 - 2024 (USD Million)
TABLE 44 Laos diagnostic application market, by type, 2013 - 2024 (USD Million)
TABLE 45 Laos therapeutic application market, by type, 2013 - 2024 (USD Million)
TABLE 46 Myanmar radiopharmaceuticals market, by product, 2013 - 2024 (USD Million)
TABLE 47 Myanmar diagnostic radiopharmaceuticals market, by product, 2013 - 2024 (USD Million)
TABLE 48 Myanmar SPECT market, by product, 2013 - 2024 (USD Million)
TABLE 49 Myanmar PET market, by product, 2013 - 2024 (USD Million)
TABLE 50 Myanmar therapeutic radiopharmaceuticals market, by product, 2013 - 2024 (USD Million)
TABLE 51 Myanmar alpha emitters market, by product, 2013 - 2024 (USD Million)
TABLE 52 Myanmar beta emitters market, by product, 2013 - 2024 (USD Million)
TABLE 53 Myanmar brachytherapy market, by product, 2013 - 2024 (USD Million)
TABLE 54 Myanmar radiopharmaceuticals market, by application, 2013 - 2024 (USD Million)
TABLE 55 Myanmar diagnostic application market, by type, 2013 - 2024 (USD Million)
TABLE 56 Myanmar therapeutic application market, by type, 2013 - 2024 (USD Million)
TABLE 57 Philippines radiopharmaceuticals market, by product, 2013 - 2024 (USD Million)
TABLE 58 Philippines diagnostic radiopharmaceuticals market, by product, 2013 - 2024 (USD Million)
TABLE 59 Philippines SPECT market, by product, 2013 - 2024 (USD Million)
TABLE 60 Philippines PET market, by product, 2013 - 2024 (USD Million)
TABLE 61 Philippines therapeutic radiopharmaceuticals market, by product, 2013 - 2024 (USD Million)
TABLE 62 Philippines alpha emitters market, by product, 2013 - 2024 (USD Million)
TABLE 63 Philippines beta emitters market, by product, 2013 - 2024 (USD Million)
TABLE 64 Philippines brachytherapy market, by product, 2013 - 2024 (USD Million)
TABLE 65 Philippines radiopharmaceuticals market, by application, 2013 - 2024 (USD Million)
TABLE 66 Philippines diagnostic application market, by type, 2013 - 2024 (USD Million)
TABLE 67 Philippines therapeutic application market, by type, 2013 - 2024 (USD Million)
TABLE 68 Malaysia radiopharmaceuticals market, by product, 2013 - 2024 (USD Million)
TABLE 69 Malaysia diagnostic radiopharmaceuticals market, by product, 2013 - 2024 (USD Million)
TABLE 70 Malaysia SPECT market, by product, 2013 - 2024 (USD Million)
TABLE 71 Malaysia PET market, by product, 2013 - 2024 (USD Million)
TABLE 72 Malaysia therapeutic radiopharmaceuticals market, by product, 2013 - 2024 (USD Million)
TABLE 73 Malaysia alpha emitters market, by product, 2013 - 2024 (USD Million)
TABLE 74 Malaysia beta emitters market, by product, 2013 - 2024 (USD Million)
TABLE 75 Malaysia brachytherapy market, by product, 2013 - 2024 (USD Million)
TABLE 76 Malaysia radiopharmaceuticals market, by application, 2013 - 2024 (USD Million)
TABLE 77 Malaysia diagnostic application market, by type, 2013 - 2024 (USD Million)
TABLE 78 Malaysia therapeutic application market, by type, 2013 - 2024 (USD Million)
TABLE 79 Vietnam radiopharmaceuticals market, by product, 2013 - 2024 (USD Million)
TABLE 80 Vietnam diagnostic radiopharmaceuticals market, by product, 2013 - 2024 (USD Million)
TABLE 81 Vietnam SPECT market, by product, 2013 - 2024 (USD Million)
TABLE 82 Vietnam PET market, by product, 2013 - 2024 (USD Million)
TABLE 83 Vietnam therapeutic radiopharmaceuticals market, by product, 2013 - 2024 (USD Million)
TABLE 84 Vietnam alpha emitters market, by product, 2013 - 2024 (USD Million)
TABLE 85 Vietnam beta emitters market, by product, 2013 - 2024 (USD Million)
TABLE 86 Vietnam brachytherapy market, by product, 2013 - 2024 (USD Million)
TABLE 87 Vietnam radiopharmaceuticals market, by application, 2013 - 2024 (USD Million)
TABLE 88 Vietnam diagnostic application market, by type, 2013 - 2024 (USD Million)
TABLE 89 Vietnam therapeutic application market, by type, 2013 - 2024 (USD Million)
TABLE 90 Cambodia radiopharmaceuticals market, by product, 2013 - 2024 (USD Million)
TABLE 91 Cambodia diagnostic radiopharmaceuticals market, by product, 2013 - 2024 (USD Million)
TABLE 92 Cambodia SPECT market, by product, 2013 - 2024 (USD Million)
TABLE 93 Cambodia PET market, by product, 2013 - 2024 (USD Million)
TABLE 94 Cambodia therapeutic radiopharmaceuticals market, by product, 2013 - 2024 (USD Million)
TABLE 95 Cambodia alpha emitters market, by product, 2013 - 2024 (USD Million)
TABLE 96 Cambodia beta emitters market, by product, 2013 - 2024 (USD Million)
TABLE 97 Cambodia brachytherapy market, by product, 2013 - 2024 (USD Million)
TABLE 98 Cambodia radiopharmaceuticals market, by application, 2013 - 2024 (USD Million)
TABLE 99 Cambodia diagnostic application market, by type, 2013 - 2024 (USD Million)
TABLE 100 Cambodia therapeutic application market, by type, 2013 - 2024 (USD Million)
TABLE 101 Rest of Asia Pacific radiopharmaceuticals market, by product, 2013 - 2024 (USD Million)
TABLE 102 Rest of Asia Pacific diagnostic radiopharmaceuticals market, by product, 2013 - 2024 (USD Million)
TABLE 103 Rest of Asia Pacific SPECT market, by product, 2013 - 2024 (USD Million)
TABLE 104 Rest of Asia Pacific PET market, by product, 2013 - 2024 (USD Million)
TABLE 105 Rest of Asia Pacific therapeutic radiopharmaceuticals market, by product, 2013 - 2024 (USD Million)
TABLE 106 Rest of Asia Pacific alpha emitters market, by product, 2013 - 2024 (USD Million)
TABLE 107 Rest of Asia Pacific beta emitters market, by product, 2013 - 2024 (USD Million)
TABLE 108 Rest of Asia Pacific brachytherapy market, by product, 2013 - 2024 (USD Million)
TABLE 109 Rest of Asia Pacific radiopharmaceuticals market, by application, 2013 - 2024 (USD Million)
TABLE 110 Rest of Asia Pacific diagnostic application market, by type, 2013 - 2024 (USD Million)
TABLE 111 Rest of Asia Pacific therapeutic application market, by type, 2013 - 2024 (USD Million)
TABLE 112 Japan radiopharmaceuticals market, by product, 2013 - 2024 (USD Million)
TABLE 113 Japan diagnostic radiopharmaceuticals market, by product, 2013 - 2024 (USD Million)
TABLE 114 Japan SPECT market, by product, 2013 - 2024 (USD Million)
TABLE 115 Japan PET market, by product, 2013 - 2024 (USD Million)
TABLE 116 Japan therapeutic radiopharmaceuticals market, by product, 2013 - 2024 (USD Million)
TABLE 117 Japan alpha emitters market, by product, 2013 - 2024 (USD Million)
TABLE 118 Japan beta emitters market, by product, 2013 - 2024 (USD Million)
TABLE 119 Japan brachytherapy market, by product, 2013 - 2024 (USD Million)
TABLE 120 Japan radiopharmaceuticals market, by application, 2013 - 2024 (USD Million)
TABLE 121 Japan diagnostic application market, by type, 2013 - 2024 (USD Million)
TABLE 122 Japan therapeutic application market, by type, 2013 - 2024 (USD Million)
TABLE 123 China radiopharmaceuticals market, by product, 2013 - 2024 (USD Million)
TABLE 124 China diagnostic radiopharmaceuticals market, by product, 2013 - 2024 (USD Million)
TABLE 125 China SPECT market, by product, 2013 - 2024 (USD Million)
TABLE 126 China PET market, by product, 2013 - 2024 (USD Million)
TABLE 127 China therapeutic radiopharmaceuticals market, by product, 2013 - 2024 (USD Million)
TABLE 128 China alpha emitters market, by product, 2013 - 2024 (USD Million)
TABLE 129 China beta emitters market, by product, 2013 - 2024 (USD Million)
TABLE 130 China brachytherapy market, by product, 2013 - 2024 (USD Million)
TABLE 131 China radiopharmaceuticals market, by application, 2013 - 2024 (USD Million)
TABLE 132 China diagnostic application market, by type, 2013 - 2024 (USD Million)
TABLE 133 China therapeutic application market, by type, 2013 - 2024 (USD Million)
TABLE 134 India radiopharmaceuticals market, by product, 2013 - 2024 (USD Million)
TABLE 135 India diagnostic radiopharmaceuticals market, by product, 2013 - 2024 (USD Million)
TABLE 136 India SPECT market, by product, 2013 - 2024 (USD Million)
TABLE 137 India PET market, by product, 2013 - 2024 (USD Million)
TABLE 138 India therapeutic radiopharmaceuticals market, by product, 2013 - 2024 (USD Million)
TABLE 139 India alpha emitters market, by product, 2013 - 2024 (USD Million)
TABLE 140 India beta emitters market, by product, 2013 - 2024 (USD Million)
TABLE 141 India brachytherapy market, by product, 2013 - 2024 (USD Million)
TABLE 142 India radiopharmaceuticals market, by application, 2013 - 2024 (USD Million)
TABLE 143 India diagnostic application market, by type, 2013 - 2024 (USD Million)
TABLE 144 India therapeutic application market, by type, 2013 - 2024 (USD Million)


List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modeling for market share assessment
FIG. 7 Market summary (USD Million, 2015)
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Global Cancer Prevalence projection,2015-2024 (Number of registered cases)
FIG. 12 Market restraint relevance analysis (Current & future impact)
FIG. 13 Radiopharmaceuticals PESTLE Analysis
FIG. 14 Porter’s Five Forces Analysis
FIG. 15 Penetration Index
FIG. 16 Radiopharmaceuticals market product outlook key takeaways
FIG. 17 Radiopharmaceuticals market: Product movement analysis
FIG. 18 Diagnostic products market, 2013 - 2024 (USD Million)
FIG. 19 SPECT products market, 2013 - 2024 (USD Million)
FIG. 20 TC-99m market, 2013 - 2024 (USD Million)
FIG. 21 TL-201 market, 2013 - 2024 (USD Million)
FIG. 22 GA-67 market, 2013 - 2024 (USD Million)
FIG. 23 I-123 market, 2013 - 2024 (USD Million)
FIG. 24 Other SPECT products market, 2013 - 2024 (USD Million)
FIG. 25 PET products market, 2013 - 2024 (USD Million)
FIG. 26 F-18 market, 2013 - 2024 (USD Million)
FIG. 27 RB-82 market, 2013 - 2024 (USD Million)
FIG. 28 Other PET products market, 2013 - 2024 (USD Million)
FIG. 29 Therapeutic products market, 2013 - 2024 (USD Million)
FIG. 30 Alpha emitters market, 2013 - 2024 (USD Million)
FIG. 31 RA-223 market, 2013 - 2024 (USD Million)
FIG. 32 Other alpha emitters market, 2013 - 2024 (USD Million)
FIG. 33 Beta emitters market, 2013 - 2024 (USD Million)
FIG. 34 I-131 market, 2013 - 2024 (USD Million)
FIG. 35 Y-90 market, 2013 - 2024 (USD Million)
FIG. 36 SM-153 market, 2013 - 2024 (USD Million)
FIG. 37 Re-186 market, 2013 - 2024 (USD Million)
FIG. 38 Lu-117 market, 2013 - 2024 (USD Million)
FIG. 39 Other beta emitters market, 2013 - 2024 (USD Million)
FIG. 40 Brachytherapy market, 2013 - 2024 (USD Million)
FIG. 41 Cesium-131 market, 2013 - 2024 (USD Million)
FIG. 42 Iodine-125 market, 2013 - 2024 (USD Million)
FIG. 43 Palladium-103 market, 2013 - 2024 (USD Million)
FIG. 44 Iridium-192 market, 2013 - 2024 (USD Million)
FIG. 45 Other brachytherapy products market, 2013 - 2024 (USD Million)
FIG. 46 Radiopharmaceuticals market application outlook key takeaways
FIG. 47 Radiopharmaceuticals market: Application movement analysis
FIG. 48 Diagnostic application market, 2013 - 2024 (USD Million)
FIG. 49 Cardiology applications market, 2013 - 2024 (USD Million)
FIG. 50 Neurology applications market, 2013 - 2024 (USD Million)
FIG. 51 Oncology applications market, 2013 - 2024 (USD Million)
FIG. 52 Thyroid applications market, 2013 - 2024 (USD Million)
FIG. 53 Lymphoma applications market, 2013 - 2024 (USD Million)
FIG. 54 Other diagnostic applications market, 2013 - 2024 (USD Million)
FIG. 55 Therapeutic application market, 2013 - 2024 (USD Million)
FIG. 56 Thyroid applications market, 2013 - 2024 (USD Million)
FIG. 57 Bone metastasis applications market, 2013 - 2024 (USD Million)
FIG. 58 Lymphoma applications market, 2013 - 2024 (USD Million)
FIG. 59 Endocrine tumor market, 2013 - 2024 (USD Million)
FIG. 60 Other therapeutic applications market, 2013 - 2024 (USD Million)
FIG. 61 Regional market place: Key takeaways
FIG. 62 Regional outlook, 2015 & 2024
FIG. 63 Southeast Asia radiopharmaceuticals market, 2013 - 2024 (USD Million)
FIG. 64 Indonesia radiopharmaceuticals market, 2013 - 2024 (USD Million)
FIG. 65 Thailand radiopharmaceuticals market, 2013 - 2024 (USD Million)
FIG. 66 Laos radiopharmaceuticals market, 2013 - 2024 (USD Million)
FIG. 67 Myanmar radiopharmaceuticals market, 2013 - 2024 (USD Million)
FIG. 68 Philippines radiopharmaceuticals market, 2013 - 2024 (USD Million)
FIG. 69 Malaysia radiopharmaceuticals market, 2013 - 2024 (USD Million)
FIG. 70 Vietnam radiopharmaceuticals market, 2013 - 2024 (USD Million)
FIG. 71 Cambodia radiopharmaceuticals market, 2013 - 2024 (USD Million)
FIG. 72 Rest of Asia Pacific radiopharmaceuticals market, 2013 - 2024 (USD Million)
FIG. 73 Japan radiopharmaceuticals market, 2013 - 2024 (USD Million)
FIG. 74 China radiopharmaceuticals market, 2013 - 2024 (USD Million)
FIG. 75 India radiopharmaceuticals market, 2013 - 2024 (USD Million)
FIG. 76 Company Profile

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.